Last Price
0.158
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Overview
Avg Volume (4 weeks)
7,421
4 Weeks Range
0.148 - 0.165
4 Weeks Price Volatility (%)
95.76%
52 Weeks Range
0.118 - 0.455
52 Weeks Price Volatility (%)
34.73%
Previous Close
0.158
Open
0.00
Bid
0.152 x 200
Ask
0.158 x 20,400
Day's Range
0.00 - 0.00
Trading Volume
0
News and Blogs
No result.
Company Profile
Sector: Health and Social Services
Sector: Health and Social Services
Description:
Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, India, Myanmar and the Philippines. The Company's segments include Banking and Diagnostics. The Banking segment consists of the collection, processing and banking of biological materials. It Banking segment includes cord blood, cord lining, cord lining mesenchymal stem cells, corneal lenticule, cord lining epithelial stem cells, cord tissue and cord tissue mesenchymal stem cells. Its Diagnostics segment includes diagnostic testing services, such as preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing, newborn metabolic screening, newborn genetic screening, pediatric vision screening, pediatric allergen test and genetic talent test. Its MOMS UP is a mobile application offering pregnancy as well as parenting resources for moms and moms-to-be in Asia.
Discussions
3 people like this. Showing 14 of 14 comments
Cordlife to Undertake Private Placement
By Sudhan P - October 3, 2013
The Motley Fool
Cordlife Group Limited (SGX: P8A), a service provider of umbilical cord blood and tissue banking with operations in Singapore, Hong Kong, India, Indonesia and The Philippines, announced that it is issuing new shares to private investors at S$1.25 per share, with up to 26,838,000 shares in total. Cordlife is looking to raise up to S$33,547,500.
2013-10-04 10:32
@lam lam what kind of answer do u wish to hear to buy, hold or sell?
2013-11-20 12:34
it has correct 18% for cordlife since making high just for your info :)
a healthy correction should be 10% think is overdone.
2013-11-20 13:16
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
RHB Investment Research Reports
ST Engineering - In-Line 9M24, Maintain Growth Expectations; Still BUY
2
3
CEO Morning Brief
Singapore Ends Pursuit of Money Launderers Who Forfeited US$1.4 Bil
4
CEO Morning Brief
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
seaviewer
I believe so
2013-01-30 12:36